Eli Lilly and Company (NYSE: LLY) will participate in the 44th Annual J.P. Morgan Healthcare Conference, Jan. 12-15, 2025.

The announcement comes weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 ...

Meanwhile, the 25-milligram dose of Novo Nordisk's oral semaglutide helped patients lose up to 16.6% of their weight on ...

Eli Lilly to invest $6 billion in new synthetic medicine facility in Huntsville, AL to boost domestic production and create ...

A computer-generated image of a large manufacturing facility. A computer-generated image of Eli Lilly and Company’s planned drug chemical plant in Houston Credit: Eli Lilly and Company Eli Lilly and ...

INDIANAPOLIS, Oct. 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2025 financial results on October 30, 2025. Lilly will also conduct a conference call that ...

HOUSTON — Seven months after Eli Lilly and Co. (NYSE: LLY) first began soliciting sites for major manufacturing proposals, Houston’s combination of tax incentives, real estate and inherent strength ...

Lilly's Zepbound price cuts ranged from $50 to $100, depending on the dosage, for consumers who pay cash via the drugmaker's ...

Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q3 2025 Earnings Conference Call. [Operator Instructions] I would now like to turn the conference over to your host, Mike ...

Eli Lilly has surged 47% since my last article, exceeding my previous $800 price target and reaching all-time highs near $1,030. LLY's leadership in the obesity treatment market continues to drive top ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Eli Lilly's CEO reveals the ...